Predictors of diabetic end-stage renal disease in Japan

Nephrology

Volumn 10, Issue SUPPL. 2, 2005, Pages

  Iseki, Kunitoshi ^a  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Diabetes mellitus; End stage renal disease; Predictors; Proteinuria; Screening

Indexed keywords

CREATININE; GLUCOSE; URIC ACID;

ADULT; BLOOD PRESSURE; BODY MASS; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATURIA; HUMAN; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; URIC ACID BLOOD LEVEL; URINALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK FACTORS;

EID: 28544438949     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00447.x     Document Type: Conference Paper

References (37)

1. Iseki K, Shinzato T, Nagura Y, Akiba T. Factors influencing long-term survival in patients on chronic dialysis. Clin. Exp. Nephrol. 2004; 8: 89-97.
2. Wakai K, Nakai S, Kikuchi K et al. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. Nephrol. Dial. Transplant. 2004; 16: 2044-52.
3. Usami T, Koyama K, Takeuchi O, Morozumi K, Kimura G. Regional variation in the incidence of end-stage renal failure in Japan. JAMA 2000; 284: 2622-4.
4. Islam MM, Horibe H, Kobayashi F. Current trend in prevalence of diabetes mellitus in Japan, 1964-1992. J. Epidemiol. 1999; 9: 155-62.
5. Lok CE, Oliver MJ, Rothwell DM, Hux JE. The growing Volume of diabetes-related dialysis: a population based study. Nephrol. Dial. Transplant. 2004; 19: 3098-103.
6. Lysaght MJ. Maintenance dialysis population dynamics, current trends and long-term implications. J. Am. Soc. Nephrol. 2002; 13 (Suppl. 1): S37-40.
7. Yamagata K, Takahashi H, Suzuki S et al. Age distribution and yearly changes in the incidence of ESRD in Japan. Am. J. Kidney Dis. 2004; 43: 433-43.
8. Iseki K, Tozawa M, Iseki C et al. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int. 2002; 61: 668-75.
9. Iseki K, Ikemiya Y, Iseki C et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003; 63: 1468-74.
10. Iseki K. The Okinawa screening program. J. Am. Soc. Nephrol. 2003; 14 (Suppl. 2): S127-S130.
11. Iseki K, Ikemiya Y, Kinjo K, Iseki C, Takishita S. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in a screened cohort. Clin. Exp. Nephrol. 2004; 8: 250-6.
12. Iseki K, Oshiro S, Tozawa M et al. Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. Hypertens. Res. 2002; 25: 185-90.
13. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int. 2001; 59: 1498-509.
14. Tozawa M, Iseki K, Iseki C et al. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002; 62: 956-62.
15. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004; 65: 1870-6.
16. Orth SR, Stockmann A, Conradt C et al. Smoking as a risk factor for end-stage renal disease in men with primary renal disease. Kidney Int. 1998; 54: 926-31.
17. Tsai AG, Walden TA. Systematic review: An evaluation of major commercial weight loss programs in the United States. Ann. Intern. Med. 2005; 142: 56-66.
18. Lee KU, Kim GS, Park JY et al. prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 1995; 18: 793-9.
19. Breyer-Lewis J. Editorial-Risky business. Kidney Int. 1999; 55: 2528-9.
20. Mandavilli A, Cyranoski D. Asia's big problem. Nat Med. 2004; 10: 325-7.
21. Schieppati A, Perico N, Remuzzi G. Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries. Kidney Int. 2003; 63: 1948-50.
22. Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: Improving global outcomes. Kidney Int. 2004; 66: 1310-4.
23. Obrador GT, Pereira BJG. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with renal failure. Am. J. Kidney Dis. 1998; 31: 398-17.
24. Jungers P, Massy ZA, Hguyen-Khoa T et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol. Dial. Transplant. 2001; 16: 2357-64.
25. Sunagawa H, Iseki K, Nishime K et al. Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 1996; 74: 361-6.
26. Iseki K, Miyasato F, Uehara H et al. Outcome study of renal biopsy patients in Okinawa, Japan. Kidney Int. 2004; 66: 914-9.
27. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec. 1992; 232: 194-201.
28. Keller G, Zimner G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N. Engl. J. Med. 2003; 348: 101-8.
29. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am. J. Kidney Dis. 1994; 23: 171-5.
30. Usami T, Nakao N, Fukuda M et al. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan. Kidney Int. 2003; 64: 1445-9.
31. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 1993; 329: 1456-62.
32. Brenner BM, Cooper ME, De Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. The RENAAL Study Investigators. N. Engl. J. Med. 2001; 345: 861-9.
33. Ruggenenti P, Fassi A, Ilieva AP et al. Preventing Microalbuminuria in type 2 diabetes. N. Engl. J Med. 2004; 351: 1941-51.
34. Boulware LE, Jaar BG, Tarver-Carr ME et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003; 290: 3101-14.
35. De Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria. Kidney Int. 2004; 66: 2109-18.
36. Glassock RJ. The rising tide of end-stage renal disease, what can be done? Clin. Exp. Nephrol. 2004; 8: 291-6.
37. Iseki K. Factors influencing the development of end-stage renal disease. Clin. Exp. Nephrol. 2005 (in press).